Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor.
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
Novel MS Drugs Advance
Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.
Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
Sex hormones and multiple sclerosis: another informative failure.
Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
Effirma, Synthetic Biologics
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.
Development of a Bilingual MS-Specific Health Classification System: The Preference-Based Multiple Sclerosis Index.
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Differing trends in the incidence of vascular comorbidity in MS and the general population.
Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
Mast cell inflammasome activity in the meninges regulates EAE disease severity.
Sleep and Cognitive Function in Multiple Sclerosis.
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis.
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study

Pages